Abstract
High-Parameter Mass Cytometry (CyTOF) Evaluation of Relapsed/Refractory Multiple Myeloma (MM) Pts (Pts) Treated with Daratumumab Supports Immune Modulation As a Novel Mechanism of Action
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have